{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Chronic obstructive pulmonary disease", "Disease severity", "Health status", "Medication adherence", "Quality of life"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34775992", "DateRevised": {"Year": "2021", "Month": "11", "Day": "18"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "11", "Day": "15"}], "Language": ["eng"], "ELocationID": ["40", "10.1186/s40780-021-00222-x"], "Journal": {"ISSN": "2055-0294", "JournalIssue": {"Volume": "7", "Issue": "1", "PubDate": {"Year": "2021", "Month": "Nov", "Day": "15"}}, "Title": "Journal of pharmaceutical health care and sciences", "ISOAbbreviation": "J Pharm Health Care Sci"}, "ArticleTitle": "Association between medication adherence and health-related quality of life in patients with chronic obstructive pulmonary disease.", "Pagination": {"StartPage": "40", "MedlinePgn": "40"}, "Abstract": {"AbstractText": ["Chronic Obstructive Pulmonary Disease (COPD) is one of the prominent cause of mortality worldwide. Nowadays, the level of medication adherence in COPD patients is very low, which reduces the clinical therapeutic effects. The purpose of the present study is to investigate the relationship between medication adherence and Health-Related Quality of Life (HRQoL) in COPD patients referred to the pulmonologist's office.", "This observational study was performed on 100 COPD outpatient cases. Each patient was interviewed to answer questionnaires regarding demographic and clinical information. To assess quality of life, health status, and severity of dyspnea, the St George's Respiratory Questionnaire - COPD-Specific Version (SGRQ-C), COPD Assessment Test (CAT), and Modified British Medical Research Council (mMRC) questionnaires were used, respectively. Persian version of the Morisky Medication Adherence Scale (MMAS-8-Item) was used to measure medication adherence. To determine the adherence predictors, an ordinal logistic regression analysis was performed.", "Out of 100 patients with mean (\u00b1SD) age of 61.35 (\u00b110.79) years, 74% had medium and high medication adherence. In the final ordinal logistic model, quality of life, health status, and education level found to have positive effect on medication adherence while polypharmacy had negative effect. We did not find any significant association between age, gender, Body Mass Index (BMI), and other variables with medication adherence.", "Patients with high quality of life are more adherent to their medications. Furthermore, patients who have polypharmacy, tend to have less adherence to their medications."], "CopyrightInformation": "\u00a9 2021. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Research Development Unit, Imam Hasan Hospital, North Khorasan University of Medical Sciences, Bojnurd, Iran."}], "LastName": "Moradkhani", "ForeName": "Boyuk", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran."}], "LastName": "Mollazadeh", "ForeName": "Samaneh", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Research Development Unit, Imam Hasan Hospital, North Khorasan University of Medical Sciences, Bojnurd, Iran."}], "LastName": "Niloofar", "ForeName": "Parastoo", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Research Development Unit, Imam Hasan Hospital, North Khorasan University of Medical Sciences, Bojnurd, Iran."}], "LastName": "Bashiri", "ForeName": "Afsaneh", "Initials": "A"}, {"Identifier": ["0000-0003-2098-613X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Research Development Unit, Imam Hasan Hospital, North Khorasan University of Medical Sciences, Bojnurd, Iran. mohammadbagher_oghazian@yahoo.com."}, {"Identifier": [], "Affiliation": "Department of Internal Medicine, Faculty of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran. mohammadbagher_oghazian@yahoo.com."}], "LastName": "Oghazian", "ForeName": "Mohammad Bagher", "Initials": "MB"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "J Pharm Health Care Sci", "NlmUniqueID": "101672177", "ISSNLinking": "2055-0294"}, "CoiStatement": "The authors declare that they have no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Chapman KR, Mannino DM, Soriano JB, Vermeire PA, Buist AS, Thun MJ, et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J. 2006;27(1):188\u2013207. doi: 10.1183/09031936.06.00024505.", "ArticleIdList": ["10.1183/09031936.06.00024505", "16387952"]}, {"Citation": "Singh D. Small airway disease in patients with chronic obstructive pulmonary disease. Tuberc Respir Dis. 2017;80(4):317\u2013324. doi: 10.4046/trd.2017.0080.", "ArticleIdList": ["10.4046/trd.2017.0080", "PMC5617847", "28905527"]}, {"Citation": "\u00c1gh T, D\u00f6m\u00f6t\u00f6r P, B\u00e1rtfai Z, Inotai A, Fujsz E, M\u00e9sz\u00e1ros \u00c1. Relationship between medication adherence and health-related quality of life in subjects with COPD: a systematic review. Respir Care. 2015;60(2):297\u2013303. doi: 10.4187/respcare.03123.", "ArticleIdList": ["10.4187/respcare.03123", "25185152"]}, {"Citation": "Lareau SC, Yawn BP. Improving adherence with inhaler therapy in COPD. Int J Chron Obstruct Pulmon Dis. 2010;5:401\u2013406. doi: 10.2147/COPD.S14715.", "ArticleIdList": ["10.2147/COPD.S14715", "PMC3008325", "21191434"]}, {"Citation": "van Boven JF, Chavannes NH, van der Molen T, Rutten-van M\u00f6lken MP, Postma MJ, Vegter S. Clinical and economic impact of non-adherence in COPD: a systematic review. Respir Med. 2014;108(1):103\u2013113. doi: 10.1016/j.rmed.2013.08.044.", "ArticleIdList": ["10.1016/j.rmed.2013.08.044", "24070566"]}, {"Citation": "L\u00f3pez-Campos JL, Quintana Gallego E, Carrasco HL. Status of and strategies for improving adherence to COPD treatment. Int J Chron Obstruct Pulmon Dis. 2019;14:1503\u20131515. doi: 10.2147/COPD.S170848.", "ArticleIdList": ["10.2147/COPD.S170848", "PMC6628097", "31371936"]}, {"Citation": "Rogliani P, Ora J, Puxeddu E, Matera MG, Cazzola M. Adherence to COPD treatment: myth and reality. Respir Med. 2017;129:117\u2013123. doi: 10.1016/j.rmed.2017.06.007.", "ArticleIdList": ["10.1016/j.rmed.2017.06.007", "28732818"]}, {"Citation": "\u00c1gh T, Inotai A, M\u00e9sz\u00e1ros \u00c1. Factors associated with medication adherence in patients with chronic obstructive pulmonary disease. Respir; Int Rev Thorac Dis. 2011;82(4):328\u2013334. doi: 10.1159/000324453.", "ArticleIdList": ["10.1159/000324453", "21454953"]}, {"Citation": "Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich) 2008;10(5):348\u2013354. doi: 10.1111/j.1751-7176.2008.07572.x.", "ArticleIdList": ["10.1111/j.1751-7176.2008.07572.x", "PMC2562622", "18453793"]}, {"Citation": "Negarandeh R, Mahmoodi H, Noktehdan H, Heshmat R, Shakibazadeh E. Teach back and pictorial image educational strategies on knowledge about diabetes and medication/dietary adherence among low health literate patients with type 2 diabetes. Prim Care Diabetes. 2013;7(2):111\u2013118. doi: 10.1016/j.pcd.2012.11.001.", "ArticleIdList": ["10.1016/j.pcd.2012.11.001", "23195913"]}, {"Citation": "Global Initiative for Chronic Obstructive Lung Disease Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease Global Initiative for Chronic Obstructive Lung Disease; 2021 [updated 2021; Accessed 1 Jul 2021 ]. Available from: http://www.goldcopd.org/."}, {"Citation": "Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581\u2013586. doi: 10.1136/thx.54.7.581.", "ArticleIdList": ["10.1136/thx.54.7.581", "PMC1745516", "10377201"]}, {"Citation": "Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline LN. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):648\u2013654. doi: 10.1183/09031936.00102509.", "ArticleIdList": ["10.1183/09031936.00102509", "19720809"]}, {"Citation": "Vetrano DL, Bianchini E, Onder G, Cricelli I, Cricelli C, Bernabei R, et al. Poor adherence to chronic obstructive pulmonary disease medications in primary care: role of age, disease burden and polypharmacy. Geriatr Gerontol Int. 2017;17(12):2500\u20132506. doi: 10.1111/ggi.13115.", "ArticleIdList": ["10.1111/ggi.13115", "28656664"]}, {"Citation": "Duarte-de-Ara\u00fajo A, Teixeira P, Hespanhol V, Correia-de-Sousa J. COPD: understanding patients\u2019 adherence to inhaled medications. Int J Chron Obstruct Pulmon Dis. 2018;13:2767\u20132773. doi: 10.2147/COPD.S160982.", "ArticleIdList": ["10.2147/COPD.S160982", "PMC6132238", "30233167"]}, {"Citation": "Moretti M, Balestracci S, Porcu A, Pianta T, Mignani D, Marsiglia B. Association of COPD inhaled medication adherence with hospitalization for acute exacerbation of COPD (AECOPD) Eur Respir J. 2017;50(suppl 61):PA676."}, {"Citation": "Kocakaya D, Olgun Y\u0131ld\u0131zeli \u015e, Ar\u0131kan H, Erbayat Y, H\u0131d\u0131ro\u011flu S, G\u00fclhan R, et al. The relationship between symptom scores and medication adherence in stable COPD patients. Eur Respir J. 2017;50(suppl 61):PA1062."}, {"Citation": "Nishi SPE, Maslonka M, Zhang W, Kuo YF, Sharma G. Pattern and adherence to maintenance medication use in medicare beneficiaries with chronic obstructive pulmonary disease: 2008\u20132013. Chron Obstruct Pulmon Dis (Miami, Fla) 2018;5(1):16\u201326.", "ArticleIdList": ["PMC5870736", "29629401"]}, {"Citation": "Schnell K, Weiss CO, Lee T, Krishnan JA, Leff B, Wolff JL, Boyd C. The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008. BMC Pulm Med. 2012;12(1):26. doi: 10.1186/1471-2466-12-26.", "ArticleIdList": ["10.1186/1471-2466-12-26", "PMC3461433", "22695054"]}, {"Citation": "Sriram KB, Percival M. Suboptimal inhaler medication adherence and incorrect technique are common among chronic obstructive pulmonary disease patients. Chron Respir Dis. 2016;13(1):13\u201322. doi: 10.1177/1479972315606313.", "ArticleIdList": ["10.1177/1479972315606313", "PMC5720197", "26396159"]}, {"Citation": "Wi\u015bniewski D, Porzezi\u0144ska M, Grucha\u0142a-Niedoszytko M, Niedoszytko M, S\u0142omi\u0144ski JM, Jassem E. Factors influencing adherence to treatment in COPD patients and its relationship with disease exacerbations. Pneumonol Alergol Pol. 2014;82(2):96\u2013104. doi: 10.5603/PiAP.2014.0015.", "ArticleIdList": ["10.5603/PiAP.2014.0015", "24615193"]}, {"Citation": "Humenberger M, Horner A, Labek A, Kaiser B, Frechinger R, Brock C, Lichtenberger P, Lamprecht B. Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD) BMC Pulm Med. 2018;18(1):163. doi: 10.1186/s12890-018-0724-3.", "ArticleIdList": ["10.1186/s12890-018-0724-3", "PMC6194635", "30340565"]}, {"Citation": "Ahn JH, Chung JH, Shin KC, Jin HJ, Jang JG, Lee MS, Lee KH. The effects of repeated inhaler device handling education in COPD patients: a prospective cohort study. Sci Rep. 2020;10(1):19676. doi: 10.1038/s41598-020-76961-y.", "ArticleIdList": ["10.1038/s41598-020-76961-y", "PMC7665176", "33184428"]}, {"Citation": "Jang JG, Kim JS, Chung JH, Shin KC, Ahn JH, Lee MS, Bang SH, Park DY, Nam MJ, Jin HJ, Lee KH. Comprehensive effects of organized education for patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2019;14:2603\u20132609. doi: 10.2147/COPD.S221673.", "ArticleIdList": ["10.2147/COPD.S221673", "PMC6883930", "31819396"]}, {"Citation": "Boland MR, van Boven JF, Kruis AL, Chavannes NH, van der Molen T, Goossens LM, et al. Investigating the association between medication adherence and health-related quality of life in COPD: methodological challenges when using a proxy measure of adherence. Respir Med. 2016;110:34\u201345. doi: 10.1016/j.rmed.2015.11.008.", "ArticleIdList": ["10.1016/j.rmed.2015.11.008", "26639189"]}, {"Citation": "Bosley CM, Corden ZM, Rees PJ, Cochrane GM. Psychological factors associated with use of home nebulized therapy for COPD. Eur Respir J. 1996;9(11):2346\u20132350. doi: 10.1183/09031936.96.09112346.", "ArticleIdList": ["10.1183/09031936.96.09112346", "8947083"]}, {"Citation": "Mohsen S, Hanafy FZ, Fathy AA, El-Gilany AH. Nonadherence to treatment and quality of life among patients with chronic obstructive pulmonary disease. Lung India. 2019;36(3):193\u2013198. doi: 10.4103/lungindia.lungindia_340_18.", "ArticleIdList": ["10.4103/lungindia.lungindia_340_18", "PMC6503717", "31031337"]}, {"Citation": "Horvat N, Locatelli I, Kos M, Jane\u017ei\u010d A. Medication adherence and health-related quality of life among patients with chronic obstructive pulmonary disease. Acta Pharm (Zagreb, Croatia) 2018;68(1):117\u2013125. doi: 10.2478/acph-2018-0006.", "ArticleIdList": ["10.2478/acph-2018-0006", "29453914"]}, {"Citation": "Jones PW. Health status measurement in chronic obstructive pulmonary disease. Thorax. 2001;56(11):880\u2013887. doi: 10.1136/thorax.56.11.880.", "ArticleIdList": ["10.1136/thorax.56.11.880", "PMC1745959", "11641515"]}, {"Citation": "Jones PW, Brusselle G, Dal Negro RW, Ferrer M, Kardos P, Levy ML, Perez T, Soler Cataluna JJ, van der Molen T, Adamek L, Banik N. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J. 2011;38(1):29\u201335. doi: 10.1183/09031936.00177210.", "ArticleIdList": ["10.1183/09031936.00177210", "21565915"]}, {"Citation": "Montes de Oca M, Menezes A, Wehrmeister FC, Lopez Varela MV, Casas A, Ugalde L, et al. Adherence to inhaled therapies of COPD patients from seven Latin American countries: the LASSYC study. PLoS One. 2017;12(11):e0186777. doi: 10.1371/journal.pone.0186777.", "ArticleIdList": ["10.1371/journal.pone.0186777", "PMC5687703", "29140978"]}, {"Citation": "M\u00fcllerov\u00e1 H, Landis SH, Aisanov Z, Davis KJ, Ichinose M, Mannino DM, Maskell J, Menezes AM, van der Molen T, Oh YM, Tabberer M, Han MK. Health behaviors and their correlates among participants in the continuing to confront COPD international patient survey. Int J Chron Obstruct Pulmon Dis. 2016;11:881\u2013890. doi: 10.2147/COPD.S102280.", "ArticleIdList": ["10.2147/COPD.S102280", "PMC4853156", "27217741"]}, {"Citation": "Vestbo J, Anderson JA, Calverley PM, Celli B, Ferguson GT, Jenkins C, et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax. 2009;64(11):939\u2013943. doi: 10.1136/thx.2009.113662.", "ArticleIdList": ["10.1136/thx.2009.113662", "19703830"]}, {"Citation": "Cramer JA, Bradley-Kennedy C, Scalera A. Treatment persistence and compliance with medications for chronic obstructive pulmonary disease. Can Respir J. 2007;14(1):25\u201329. doi: 10.1155/2007/161652.", "ArticleIdList": ["10.1155/2007/161652", "PMC2690446", "17315055"]}, {"Citation": "Laforest L, Denis F, Van Ganse E, Ritleng C, Saussier C, Passante N, et al. Correlates of adherence to respiratory drugs in COPD patients. Prim Care Respir J. 2010;19(2):148\u2013154. doi: 10.4104/pcrj.2010.00004.", "ArticleIdList": ["10.4104/pcrj.2010.00004", "PMC6602228", "20094689"]}, {"Citation": "Horne R, Chapman SC, Parham R, Freemantle N, Forbes A, Cooper V. Understanding patients\u2019 adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the necessity-concerns framework. PLoS One. 2013;8(12):e80633. doi: 10.1371/journal.pone.0080633.", "ArticleIdList": ["10.1371/journal.pone.0080633", "PMC3846635", "24312488"]}, {"Citation": "Rand CS. Patient adherence with COPD therapy. Eur Respir Rev. 2005;14(96):97\u2013101. doi: 10.1183/09059180.05.00009604.", "ArticleIdList": ["10.1183/09059180.05.00009604"]}, {"Citation": "Ierodiakonou D, Sifaki-Pistolla D, Kampouraki M, Poulorinakis I, Papadokostakis P, Gialamas I, et al. Adherence to inhalers and comorbidities in COPD patients. A cross-sectional primary care study from Greece. BMC Pulm Med. 2020;20(1):253. doi: 10.1186/s12890-020-01296-3.", "ArticleIdList": ["10.1186/s12890-020-01296-3", "PMC7519509", "32977779"]}, {"Citation": "Vestbo J, Pauwels R, Anderson JA, Jones P, Calverley P. Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease. Thorax. 2005;60(4):301\u2013304. doi: 10.1136/thx.2004.025411.", "ArticleIdList": ["10.1136/thx.2004.025411", "PMC1747357", "15790985"]}, {"Citation": "Bourbeau J, Bartlett SJ. Patient adherence in COPD. Thorax. 2008;63(9):831\u2013838. doi: 10.1136/thx.2007.086041.", "ArticleIdList": ["10.1136/thx.2007.086041", "PMC4747423", "18728206"]}, {"Citation": "Khdour MR, Hawwa AF, Kidney JC, Smyth BM, McElnay JC. Potential risk factors for medication non-adherence in patients with chronic obstructive pulmonary disease (COPD) Eur J Clin Pharmacol. 2012;68(10):1365\u20131373. doi: 10.1007/s00228-012-1279-5.", "ArticleIdList": ["10.1007/s00228-012-1279-5", "22476392"]}, {"Citation": "Kokturk N, Polatli M, Oguzulgen IK, Saleemi S, Al Ghobain M, Khan J, et al. Adherence to COPD treatment in Turkey and Saudi Arabia: results of the ADCARE study. Int J Chron Obstruct Pulmon Dis. 2018;13:1377\u20131388. doi: 10.2147/COPD.S150411.", "ArticleIdList": ["10.2147/COPD.S150411", "PMC5927343", "29731625"]}, {"Citation": "Cecere LM, Slatore CG, Uman JE, Evans LE, Udris EM, Bryson CL, Au DH. Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD) Copd. 2012;9(3):251\u2013258. doi: 10.3109/15412555.2011.650241.", "ArticleIdList": ["10.3109/15412555.2011.650241", "22497533"]}, {"Citation": "Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23(8):1296\u20131310. doi: 10.1016/S0149-2918(01)80109-0.", "ArticleIdList": ["10.1016/S0149-2918(01)80109-0", "11558866"]}, {"Citation": "Franssen FM, Spruit MA, Wouters EF. Determinants of polypharmacy and compliance with GOLD guidelines in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2011;6:493\u2013501. doi: 10.2147/COPD.S24443.", "ArticleIdList": ["10.2147/COPD.S24443", "PMC3206765", "22069360"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "6", "Day": "8"}, {"Year": "2021", "Month": "8", "Day": "23"}, {"Year": "2021", "Month": "11", "Day": "15", "Hour": "5", "Minute": "40"}, {"Year": "2021", "Month": "11", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "11", "Day": "16", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "11", "Day": "15"}], "PublicationStatus": "epublish", "ArticleIdList": ["34775992", "PMC8591943", "10.1186/s40780-021-00222-x", "10.1186/s40780-021-00222-x"]}}], "PubmedBookArticle": []}